Companies: 10,795·Total market cap: $144.5T
Tekla Life Sciences Investors

Tekla Life Sciences Investors

HQLNYSEFinancial Services● Active
$16.61
$-0.31(-1.83%)
Market Cap$505076880
P/E Ratio
52W High$18.46
52W Low$12.34

Tekla Life Sciences Investors (HQL) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · HQL · as of Jun 8, 2026

Activity summary

Buy transactions

1

P-Purchase only

Sell transactions

39

12 Months

Buy/Sell ratio

0.03

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 3%Active transactions only · RSU vesting excluded97% Sell ↓

Tekla Life Sciences Investors insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

HQL insider buying and selling by quarter

HQL insider selling · HQL insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
818K409K0
2025 Q1
2025 Q2
2025 Q3
2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · HQL ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

HQL executive sell shares · HQL board member insider trading · HQL insider trading SEC filing

Showing 76 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Pittard Christian

Director

Purchase

Date

Dec 16

Shares

7,923

Price

$16.88

Value

$134K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 19

Shares

6,989

Price

$14.10

Value

$99K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 22

Shares

41,623

Price

$14.14

Value

$589K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 17

Shares

24,328

Price

$13.99

Value

$340K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 18

Shares

40,208

Price

$14.07

Value

$566K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 15

Shares

700

Price

$14.13

Value

$10K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 16

Shares

2,026

Price

$13.99

Value

$28K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 11

Shares

15,116

Price

$14.28

Value

$216K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Sep 2

Shares

14,083

Price

$14.04

Value

$198K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Aug 29

Shares

23,723

Price

$13.89

Value

$330K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Aug 26

Shares

400

Price

$13.83

Value

$6K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Aug 21

Shares

10,710

Price

$14.07

Value

$151K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

May 20

Shares

11,419

Price

$12.71

Value

$145K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

May 15

Shares

23,729

Price

$12.08

Value

$287K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

May 13

Shares

730

Price

$12.28

Value

$9K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

May 14

Shares

600

Price

$12.04

Value

$7K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

May 8

Shares

12,689

Price

$11.98

Value

$152K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

May 7

Shares

1,366

Price

$12.19

Value

$17K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Apr 17

Shares

9,144

Price

$11.78

Value

$108K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Apr 15

Shares

1,700

Price

$11.92

Value

$20K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Apr 14

Shares

15,400

Price

$11.67

Value

$180K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Apr 10

Shares

30,156

Price

$11.14

Value

$336K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Apr 3

Shares

10,321

Price

$12.23

Value

$126K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Apr 4

Shares

6,889

Price

$11.57

Value

$80K

View Form 4 on SEC.gov

Saba Capital Management, L.P.

10 percent owner

Sale

Date

Apr 1

Shares

17,621

Price

$12.45

Value

$219K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About HQL insider trading

HQL insider trades

Tekla Life Sciences Investors (HQL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Saba Capital Management, L.P. (10 percent owner), Pittard Christian (Director). Over the past 12 months, 2 insiders have filed transactions with the SEC. HQL insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Tekla Life Sciences Investors's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

HQL insider trading · 5 questions

The insiders of Tekla Life Sciences Investors (HQL) include executives and directors such as Saba Capital Management, L.P. (10 percent owner), Pittard Christian (Director), among others. Over the past 12 months, 2 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

HQL board member insider tradingwho are HQL insidersHQL insider rosterTekla Life Sciences Investors executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026